nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—ABCB1—colon cancer	0.353	1	CbGaD
Temsirolimus—CYP3A7—Irinotecan—colon cancer	0.0534	0.145	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0534	0.145	CbGbCtD
Temsirolimus—CYP3A7—Vincristine—colon cancer	0.0467	0.127	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0467	0.127	CbGbCtD
Temsirolimus—CYP3A5—Irinotecan—colon cancer	0.0401	0.109	CbGbCtD
Temsirolimus—CYP3A5—Vincristine—colon cancer	0.035	0.0954	CbGbCtD
Temsirolimus—ABCB1—Irinotecan—colon cancer	0.0261	0.071	CbGbCtD
Temsirolimus—ABCB1—Vincristine—colon cancer	0.0228	0.0621	CbGbCtD
Temsirolimus—CYP3A4—Irinotecan—colon cancer	0.0156	0.0425	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—colon cancer	0.0138	0.0376	CbGbCtD
Temsirolimus—CYP3A4—Vincristine—colon cancer	0.0137	0.0372	CbGbCtD
Temsirolimus—MTOR—blood vessel—colon cancer	0.00377	0.0946	CbGeAlD
Temsirolimus—MTOR—embryo—colon cancer	0.00225	0.0564	CbGeAlD
Temsirolimus—MTOR—epithelium—colon cancer	0.00183	0.0461	CbGeAlD
Temsirolimus—MTOR—smooth muscle tissue—colon cancer	0.00177	0.0444	CbGeAlD
Temsirolimus—MTOR—renal system—colon cancer	0.0017	0.0427	CbGeAlD
Temsirolimus—FKBP1A—epithelium—colon cancer	0.00165	0.0414	CbGeAlD
Temsirolimus—FKBP1A—smooth muscle tissue—colon cancer	0.00159	0.0399	CbGeAlD
Temsirolimus—FKBP1A—renal system—colon cancer	0.00153	0.0384	CbGeAlD
Temsirolimus—MTOR—lymphoid tissue—colon cancer	0.00141	0.0355	CbGeAlD
Temsirolimus—MTOR—digestive system—colon cancer	0.00139	0.035	CbGeAlD
Temsirolimus—MTOR—bone marrow—colon cancer	0.00129	0.0323	CbGeAlD
Temsirolimus—FKBP1A—lymphoid tissue—colon cancer	0.00127	0.0319	CbGeAlD
Temsirolimus—FKBP1A—digestive system—colon cancer	0.00125	0.0315	CbGeAlD
Temsirolimus—MTOR—vagina—colon cancer	0.00123	0.0309	CbGeAlD
Temsirolimus—FKBP1A—bone marrow—colon cancer	0.00116	0.029	CbGeAlD
Temsirolimus—CYP3A7—liver—colon cancer	0.00116	0.029	CbGeAlD
Temsirolimus—FKBP1A—vagina—colon cancer	0.00111	0.0278	CbGeAlD
Temsirolimus—MTOR—liver—colon cancer	0.00104	0.0261	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—colon cancer	0.000983	0.0247	CbGeAlD
Temsirolimus—FKBP1A—liver—colon cancer	0.000935	0.0235	CbGeAlD
Temsirolimus—MTOR—lymph node—colon cancer	0.000797	0.02	CbGeAlD
Temsirolimus—ABCB1—blood vessel—colon cancer	0.000784	0.0197	CbGeAlD
Temsirolimus—FKBP1A—lymph node—colon cancer	0.000717	0.018	CbGeAlD
Temsirolimus—Sirolimus—ABCB1—colon cancer	0.000695	0.5	CrCbGaD
Temsirolimus—Tacrolimus—ABCB1—colon cancer	0.000695	0.5	CrCbGaD
Temsirolimus—CYP3A5—renal system—colon cancer	0.000666	0.0167	CbGeAlD
Temsirolimus—CYP3A5—digestive system—colon cancer	0.000546	0.0137	CbGeAlD
Temsirolimus—CYP3A4—renal system—colon cancer	0.0005	0.0126	CbGeAlD
Temsirolimus—CYP2D6—renal system—colon cancer	0.000492	0.0124	CbGeAlD
Temsirolimus—CYP3A5—vagina—colon cancer	0.000482	0.0121	CbGeAlD
Temsirolimus—ABCB1—embryo—colon cancer	0.000467	0.0117	CbGeAlD
Temsirolimus—CYP3A4—digestive system—colon cancer	0.00041	0.0103	CbGeAlD
Temsirolimus—CYP3A5—liver—colon cancer	0.000407	0.0102	CbGeAlD
Temsirolimus—CYP2D6—digestive system—colon cancer	0.000403	0.0101	CbGeAlD
Temsirolimus—ABCB1—epithelium—colon cancer	0.000381	0.00958	CbGeAlD
Temsirolimus—ABCB1—renal system—colon cancer	0.000354	0.00889	CbGeAlD
Temsirolimus—Angiopathy—Vincristine—colon cancer	0.000334	0.00225	CcSEcCtD
Temsirolimus—Cardiac disorder—Irinotecan—colon cancer	0.000332	0.00224	CcSEcCtD
Temsirolimus—Mediastinal disorder—Vincristine—colon cancer	0.000331	0.00224	CcSEcCtD
Temsirolimus—Angiopathy—Irinotecan—colon cancer	0.000325	0.00219	CcSEcCtD
Temsirolimus—Blood creatinine increased—Capecitabine—colon cancer	0.000325	0.00219	CcSEcCtD
Temsirolimus—Immune system disorder—Irinotecan—colon cancer	0.000323	0.00218	CcSEcCtD
Temsirolimus—Mediastinal disorder—Irinotecan—colon cancer	0.000323	0.00218	CcSEcCtD
Temsirolimus—Dehydration—Capecitabine—colon cancer	0.000322	0.00218	CcSEcCtD
Temsirolimus—Mental disorder—Vincristine—colon cancer	0.000322	0.00218	CcSEcCtD
Temsirolimus—Chills—Irinotecan—colon cancer	0.000321	0.00217	CcSEcCtD
Temsirolimus—Bladder pain—Methotrexate—colon cancer	0.000321	0.00217	CcSEcCtD
Temsirolimus—Ecchymosis—Methotrexate—colon cancer	0.000321	0.00217	CcSEcCtD
Temsirolimus—Mouth ulceration—Methotrexate—colon cancer	0.000321	0.00217	CcSEcCtD
Temsirolimus—Dry skin—Capecitabine—colon cancer	0.000318	0.00214	CcSEcCtD
Temsirolimus—Hypokalaemia—Capecitabine—colon cancer	0.000315	0.00213	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000312	0.00211	CcSEcCtD
Temsirolimus—Back pain—Vincristine—colon cancer	0.00031	0.00209	CcSEcCtD
Temsirolimus—Sepsis—Methotrexate—colon cancer	0.000308	0.00208	CcSEcCtD
Temsirolimus—Gastritis—Capecitabine—colon cancer	0.000307	0.00207	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000306	0.00206	CcSEcCtD
Temsirolimus—CYP3A4—liver—colon cancer	0.000305	0.00767	CbGeAlD
Temsirolimus—Back pain—Irinotecan—colon cancer	0.000302	0.00204	CcSEcCtD
Temsirolimus—Abdominal distension—Capecitabine—colon cancer	0.000301	0.00204	CcSEcCtD
Temsirolimus—CYP2D6—liver—colon cancer	0.000301	0.00755	CbGeAlD
Temsirolimus—Influenza—Capecitabine—colon cancer	0.000299	0.00202	CcSEcCtD
Temsirolimus—Dysphagia—Capecitabine—colon cancer	0.000299	0.00202	CcSEcCtD
Temsirolimus—Erythema—Fluorouracil—colon cancer	0.000299	0.00202	CcSEcCtD
Temsirolimus—Thrombophlebitis—Methotrexate—colon cancer	0.000298	0.00201	CcSEcCtD
Temsirolimus—Diabetes mellitus—Methotrexate—colon cancer	0.000296	0.002	CcSEcCtD
Temsirolimus—Anaemia—Vincristine—colon cancer	0.000296	0.002	CcSEcCtD
Temsirolimus—ABCB1—lymphoid tissue—colon cancer	0.000294	0.00738	CbGeAlD
Temsirolimus—ABCB1—digestive system—colon cancer	0.00029	0.00729	CbGeAlD
Temsirolimus—Anaemia—Irinotecan—colon cancer	0.000288	0.00195	CcSEcCtD
Temsirolimus—Bronchitis—Capecitabine—colon cancer	0.000288	0.00194	CcSEcCtD
Temsirolimus—Leukopenia—Vincristine—colon cancer	0.000287	0.00194	CcSEcCtD
Temsirolimus—Neutropenia—Capecitabine—colon cancer	0.00028	0.00189	CcSEcCtD
Temsirolimus—Dysuria—Capecitabine—colon cancer	0.00028	0.00189	CcSEcCtD
Temsirolimus—Leukopenia—Irinotecan—colon cancer	0.000279	0.00188	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Capecitabine—colon cancer	0.000278	0.00188	CcSEcCtD
Temsirolimus—Convulsion—Vincristine—colon cancer	0.000277	0.00187	CcSEcCtD
Temsirolimus—Hypertension—Vincristine—colon cancer	0.000276	0.00187	CcSEcCtD
Temsirolimus—Anaemia—Fluorouracil—colon cancer	0.000276	0.00186	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Methotrexate—colon cancer	0.000273	0.00185	CcSEcCtD
Temsirolimus—Myalgia—Vincristine—colon cancer	0.000272	0.00184	CcSEcCtD
Temsirolimus—Cough—Irinotecan—colon cancer	0.000272	0.00184	CcSEcCtD
Temsirolimus—Weight decreased—Capecitabine—colon cancer	0.000271	0.00183	CcSEcCtD
Temsirolimus—Hyperglycaemia—Capecitabine—colon cancer	0.00027	0.00182	CcSEcCtD
Temsirolimus—Hypertension—Irinotecan—colon cancer	0.000269	0.00182	CcSEcCtD
Temsirolimus—Pneumonia—Capecitabine—colon cancer	0.000269	0.00181	CcSEcCtD
Temsirolimus—ABCB1—bone marrow—colon cancer	0.000268	0.00672	CbGeAlD
Temsirolimus—Leukopenia—Fluorouracil—colon cancer	0.000267	0.0018	CcSEcCtD
Temsirolimus—Infestation NOS—Capecitabine—colon cancer	0.000267	0.0018	CcSEcCtD
Temsirolimus—Infestation—Capecitabine—colon cancer	0.000267	0.0018	CcSEcCtD
Temsirolimus—Depression—Capecitabine—colon cancer	0.000266	0.0018	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000265	0.00179	CcSEcCtD
Temsirolimus—Renal failure—Capecitabine—colon cancer	0.000262	0.00177	CcSEcCtD
Temsirolimus—Anaphylactic shock—Vincristine—colon cancer	0.000261	0.00176	CcSEcCtD
Temsirolimus—Oedema—Vincristine—colon cancer	0.000261	0.00176	CcSEcCtD
Temsirolimus—Stomatitis—Capecitabine—colon cancer	0.00026	0.00176	CcSEcCtD
Temsirolimus—Infection—Vincristine—colon cancer	0.00026	0.00175	CcSEcCtD
Temsirolimus—Urinary tract infection—Capecitabine—colon cancer	0.000259	0.00175	CcSEcCtD
Temsirolimus—Conjunctivitis—Capecitabine—colon cancer	0.000259	0.00175	CcSEcCtD
Temsirolimus—Convulsion—Fluorouracil—colon cancer	0.000259	0.00175	CcSEcCtD
Temsirolimus—ABCB1—vagina—colon cancer	0.000256	0.00644	CbGeAlD
Temsirolimus—Nervous system disorder—Vincristine—colon cancer	0.000256	0.00173	CcSEcCtD
Temsirolimus—Thrombocytopenia—Vincristine—colon cancer	0.000256	0.00173	CcSEcCtD
Temsirolimus—Haematuria—Capecitabine—colon cancer	0.000255	0.00172	CcSEcCtD
Temsirolimus—Anaphylactic shock—Irinotecan—colon cancer	0.000254	0.00172	CcSEcCtD
Temsirolimus—Oedema—Irinotecan—colon cancer	0.000254	0.00172	CcSEcCtD
Temsirolimus—Chest pain—Fluorouracil—colon cancer	0.000254	0.00172	CcSEcCtD
Temsirolimus—Myalgia—Fluorouracil—colon cancer	0.000254	0.00172	CcSEcCtD
Temsirolimus—Infection—Irinotecan—colon cancer	0.000253	0.00171	CcSEcCtD
Temsirolimus—Epistaxis—Capecitabine—colon cancer	0.000252	0.0017	CcSEcCtD
Temsirolimus—Nervous system disorder—Irinotecan—colon cancer	0.000249	0.00169	CcSEcCtD
Temsirolimus—Thrombocytopenia—Irinotecan—colon cancer	0.000249	0.00168	CcSEcCtD
Temsirolimus—Anorexia—Vincristine—colon cancer	0.000249	0.00168	CcSEcCtD
Temsirolimus—Oedema—Fluorouracil—colon cancer	0.000244	0.00165	CcSEcCtD
Temsirolimus—Anaphylactic shock—Fluorouracil—colon cancer	0.000244	0.00165	CcSEcCtD
Temsirolimus—Anorexia—Irinotecan—colon cancer	0.000242	0.00164	CcSEcCtD
Temsirolimus—Infection—Fluorouracil—colon cancer	0.000242	0.00163	CcSEcCtD
Temsirolimus—Rhinitis—Capecitabine—colon cancer	0.00024	0.00162	CcSEcCtD
Temsirolimus—Nervous system disorder—Fluorouracil—colon cancer	0.000239	0.00161	CcSEcCtD
Temsirolimus—Thrombocytopenia—Fluorouracil—colon cancer	0.000239	0.00161	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Vincristine—colon cancer	0.000238	0.00161	CcSEcCtD
Temsirolimus—Pharyngitis—Capecitabine—colon cancer	0.000238	0.00161	CcSEcCtD
Temsirolimus—Urinary tract disorder—Capecitabine—colon cancer	0.000237	0.0016	CcSEcCtD
Temsirolimus—Insomnia—Vincristine—colon cancer	0.000236	0.0016	CcSEcCtD
Temsirolimus—Oedema peripheral—Capecitabine—colon cancer	0.000236	0.00159	CcSEcCtD
Temsirolimus—Connective tissue disorder—Capecitabine—colon cancer	0.000236	0.00159	CcSEcCtD
Temsirolimus—Urethral disorder—Capecitabine—colon cancer	0.000235	0.00159	CcSEcCtD
Temsirolimus—Anorexia—Fluorouracil—colon cancer	0.000232	0.00157	CcSEcCtD
Temsirolimus—Insomnia—Irinotecan—colon cancer	0.00023	0.00155	CcSEcCtD
Temsirolimus—Decreased appetite—Vincristine—colon cancer	0.000227	0.00153	CcSEcCtD
Temsirolimus—Dyspnoea—Irinotecan—colon cancer	0.000227	0.00153	CcSEcCtD
Temsirolimus—Erythema multiforme—Capecitabine—colon cancer	0.000227	0.00153	CcSEcCtD
Temsirolimus—Somnolence—Irinotecan—colon cancer	0.000226	0.00153	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Vincristine—colon cancer	0.000226	0.00152	CcSEcCtD
Temsirolimus—Fatigue—Vincristine—colon cancer	0.000225	0.00152	CcSEcCtD
Temsirolimus—Eye disorder—Capecitabine—colon cancer	0.000224	0.00151	CcSEcCtD
Temsirolimus—Constipation—Vincristine—colon cancer	0.000223	0.00151	CcSEcCtD
Temsirolimus—Pain—Vincristine—colon cancer	0.000223	0.00151	CcSEcCtD
Temsirolimus—Cardiac disorder—Capecitabine—colon cancer	0.000222	0.0015	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000222	0.0015	CcSEcCtD
Temsirolimus—Decreased appetite—Irinotecan—colon cancer	0.000221	0.00149	CcSEcCtD
Temsirolimus—Insomnia—Fluorouracil—colon cancer	0.00022	0.00149	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Irinotecan—colon cancer	0.00022	0.00148	CcSEcCtD
Temsirolimus—Fatigue—Irinotecan—colon cancer	0.000219	0.00148	CcSEcCtD
Temsirolimus—Pain—Irinotecan—colon cancer	0.000218	0.00147	CcSEcCtD
Temsirolimus—Constipation—Irinotecan—colon cancer	0.000218	0.00147	CcSEcCtD
Temsirolimus—Angiopathy—Capecitabine—colon cancer	0.000217	0.00147	CcSEcCtD
Temsirolimus—Dyspnoea—Fluorouracil—colon cancer	0.000217	0.00147	CcSEcCtD
Temsirolimus—Somnolence—Fluorouracil—colon cancer	0.000217	0.00146	CcSEcCtD
Temsirolimus—Immune system disorder—Capecitabine—colon cancer	0.000216	0.00146	CcSEcCtD
Temsirolimus—ABCB1—liver—colon cancer	0.000216	0.00543	CbGeAlD
Temsirolimus—Mediastinal disorder—Capecitabine—colon cancer	0.000216	0.00146	CcSEcCtD
Temsirolimus—Chills—Capecitabine—colon cancer	0.000215	0.00145	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Vincristine—colon cancer	0.000214	0.00144	CcSEcCtD
Temsirolimus—Decreased appetite—Fluorouracil—colon cancer	0.000212	0.00143	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00021	0.00142	CcSEcCtD
Temsirolimus—Mental disorder—Capecitabine—colon cancer	0.00021	0.00142	CcSEcCtD
Temsirolimus—Malnutrition—Capecitabine—colon cancer	0.000209	0.00141	CcSEcCtD
Temsirolimus—Erythema—Capecitabine—colon cancer	0.000209	0.00141	CcSEcCtD
Temsirolimus—Neutropenia—Methotrexate—colon cancer	0.000208	0.00141	CcSEcCtD
Temsirolimus—Dysuria—Methotrexate—colon cancer	0.000208	0.00141	CcSEcCtD
Temsirolimus—Pain—Fluorouracil—colon cancer	0.000208	0.00141	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Irinotecan—colon cancer	0.000208	0.00141	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Methotrexate—colon cancer	0.000207	0.0014	CcSEcCtD
Temsirolimus—Body temperature increased—Vincristine—colon cancer	0.000206	0.00139	CcSEcCtD
Temsirolimus—Abdominal pain—Vincristine—colon cancer	0.000206	0.00139	CcSEcCtD
Temsirolimus—Dysgeusia—Capecitabine—colon cancer	0.000204	0.00138	CcSEcCtD
Temsirolimus—Back pain—Capecitabine—colon cancer	0.000202	0.00136	CcSEcCtD
Temsirolimus—Abdominal pain—Irinotecan—colon cancer	0.000201	0.00136	CcSEcCtD
Temsirolimus—Body temperature increased—Irinotecan—colon cancer	0.000201	0.00136	CcSEcCtD
Temsirolimus—Pneumonia—Methotrexate—colon cancer	0.0002	0.00135	CcSEcCtD
Temsirolimus—Infestation NOS—Methotrexate—colon cancer	0.000199	0.00134	CcSEcCtD
Temsirolimus—Infestation—Methotrexate—colon cancer	0.000199	0.00134	CcSEcCtD
Temsirolimus—Depression—Methotrexate—colon cancer	0.000198	0.00134	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000197	0.00133	CcSEcCtD
Temsirolimus—Renal failure—Methotrexate—colon cancer	0.000195	0.00132	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—colon cancer	0.000194	0.00131	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—colon cancer	0.000193	0.0013	CcSEcCtD
Temsirolimus—Anaemia—Capecitabine—colon cancer	0.000193	0.0013	CcSEcCtD
Temsirolimus—Body temperature increased—Fluorouracil—colon cancer	0.000193	0.0013	CcSEcCtD
Temsirolimus—Hypersensitivity—Vincristine—colon cancer	0.000192	0.0013	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—colon cancer	0.000189	0.00128	CcSEcCtD
Temsirolimus—Epistaxis—Methotrexate—colon cancer	0.000187	0.00127	CcSEcCtD
Temsirolimus—Hypersensitivity—Irinotecan—colon cancer	0.000187	0.00127	CcSEcCtD
Temsirolimus—Asthenia—Vincristine—colon cancer	0.000187	0.00127	CcSEcCtD
Temsirolimus—Leukopenia—Capecitabine—colon cancer	0.000187	0.00126	CcSEcCtD
Temsirolimus—Asthenia—Irinotecan—colon cancer	0.000183	0.00123	CcSEcCtD
Temsirolimus—Cough—Capecitabine—colon cancer	0.000182	0.00123	CcSEcCtD
Temsirolimus—Hypertension—Capecitabine—colon cancer	0.00018	0.00122	CcSEcCtD
Temsirolimus—Hypersensitivity—Fluorouracil—colon cancer	0.00018	0.00121	CcSEcCtD
Temsirolimus—Diarrhoea—Vincristine—colon cancer	0.000179	0.00121	CcSEcCtD
Temsirolimus—Arthralgia—Capecitabine—colon cancer	0.000178	0.0012	CcSEcCtD
Temsirolimus—Chest pain—Capecitabine—colon cancer	0.000178	0.0012	CcSEcCtD
Temsirolimus—Myalgia—Capecitabine—colon cancer	0.000178	0.0012	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—colon cancer	0.000177	0.0012	CcSEcCtD
Temsirolimus—Anxiety—Capecitabine—colon cancer	0.000177	0.0012	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000176	0.00119	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—colon cancer	0.000176	0.00119	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—colon cancer	0.000175	0.00118	CcSEcCtD
Temsirolimus—Diarrhoea—Irinotecan—colon cancer	0.000174	0.00118	CcSEcCtD
Temsirolimus—Dizziness—Vincristine—colon cancer	0.000173	0.00117	CcSEcCtD
Temsirolimus—Pruritus—Fluorouracil—colon cancer	0.000172	0.00116	CcSEcCtD
Temsirolimus—Oedema—Capecitabine—colon cancer	0.00017	0.00115	CcSEcCtD
Temsirolimus—Infection—Capecitabine—colon cancer	0.000169	0.00114	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—colon cancer	0.000169	0.00114	CcSEcCtD
Temsirolimus—Dizziness—Irinotecan—colon cancer	0.000168	0.00114	CcSEcCtD
Temsirolimus—Nervous system disorder—Capecitabine—colon cancer	0.000167	0.00113	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—colon cancer	0.000167	0.00113	CcSEcCtD
Temsirolimus—Diarrhoea—Fluorouracil—colon cancer	0.000167	0.00113	CcSEcCtD
Temsirolimus—Thrombocytopenia—Capecitabine—colon cancer	0.000167	0.00113	CcSEcCtD
Temsirolimus—Vomiting—Vincristine—colon cancer	0.000166	0.00112	CcSEcCtD
Temsirolimus—ABCB1—lymph node—colon cancer	0.000166	0.00416	CbGeAlD
Temsirolimus—Cardiac disorder—Methotrexate—colon cancer	0.000166	0.00112	CcSEcCtD
Temsirolimus—Skin disorder—Capecitabine—colon cancer	0.000165	0.00112	CcSEcCtD
Temsirolimus—Rash—Vincristine—colon cancer	0.000165	0.00111	CcSEcCtD
Temsirolimus—Dermatitis—Vincristine—colon cancer	0.000165	0.00111	CcSEcCtD
Temsirolimus—Headache—Vincristine—colon cancer	0.000164	0.00111	CcSEcCtD
Temsirolimus—Anorexia—Capecitabine—colon cancer	0.000162	0.0011	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—colon cancer	0.000162	0.00109	CcSEcCtD
Temsirolimus—Vomiting—Irinotecan—colon cancer	0.000162	0.00109	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—colon cancer	0.000161	0.00109	CcSEcCtD
Temsirolimus—Dizziness—Fluorouracil—colon cancer	0.000161	0.00109	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—colon cancer	0.000161	0.00109	CcSEcCtD
Temsirolimus—Rash—Irinotecan—colon cancer	0.00016	0.00108	CcSEcCtD
Temsirolimus—Dermatitis—Irinotecan—colon cancer	0.00016	0.00108	CcSEcCtD
Temsirolimus—Chills—Methotrexate—colon cancer	0.00016	0.00108	CcSEcCtD
Temsirolimus—Headache—Irinotecan—colon cancer	0.000159	0.00108	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—colon cancer	0.000156	0.00106	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—colon cancer	0.000155	0.00105	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—colon cancer	0.000155	0.00105	CcSEcCtD
Temsirolimus—Nausea—Vincristine—colon cancer	0.000155	0.00105	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000155	0.00105	CcSEcCtD
Temsirolimus—Vomiting—Fluorouracil—colon cancer	0.000155	0.00105	CcSEcCtD
Temsirolimus—Insomnia—Capecitabine—colon cancer	0.000154	0.00104	CcSEcCtD
Temsirolimus—Rash—Fluorouracil—colon cancer	0.000154	0.00104	CcSEcCtD
Temsirolimus—Dermatitis—Fluorouracil—colon cancer	0.000153	0.00104	CcSEcCtD
Temsirolimus—Headache—Fluorouracil—colon cancer	0.000153	0.00103	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—colon cancer	0.000152	0.00103	CcSEcCtD
Temsirolimus—Dyspnoea—Capecitabine—colon cancer	0.000152	0.00103	CcSEcCtD
Temsirolimus—Nausea—Irinotecan—colon cancer	0.000151	0.00102	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—colon cancer	0.00015	0.00101	CcSEcCtD
Temsirolimus—Decreased appetite—Capecitabine—colon cancer	0.000148	0.001	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Capecitabine—colon cancer	0.000147	0.000993	CcSEcCtD
Temsirolimus—Fatigue—Capecitabine—colon cancer	0.000147	0.000991	CcSEcCtD
Temsirolimus—Constipation—Capecitabine—colon cancer	0.000146	0.000983	CcSEcCtD
Temsirolimus—Pain—Capecitabine—colon cancer	0.000146	0.000983	CcSEcCtD
Temsirolimus—Nausea—Fluorouracil—colon cancer	0.000145	0.000978	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—colon cancer	0.000144	0.00097	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Capecitabine—colon cancer	0.000139	0.00094	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—colon cancer	0.000139	0.000939	CcSEcCtD
Temsirolimus—Cough—Methotrexate—colon cancer	0.000136	0.000915	CcSEcCtD
Temsirolimus—Abdominal pain—Capecitabine—colon cancer	0.000135	0.000909	CcSEcCtD
Temsirolimus—Body temperature increased—Capecitabine—colon cancer	0.000135	0.000909	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—colon cancer	0.000135	0.000909	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—colon cancer	0.000132	0.000893	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—colon cancer	0.000132	0.000893	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—colon cancer	0.000132	0.000893	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000131	0.000887	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—colon cancer	0.000127	0.000856	CcSEcCtD
Temsirolimus—Infection—Methotrexate—colon cancer	0.000126	0.000851	CcSEcCtD
Temsirolimus—Hypersensitivity—Capecitabine—colon cancer	0.000125	0.000847	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—colon cancer	0.000124	0.00084	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—colon cancer	0.000124	0.000838	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—colon cancer	0.000123	0.000832	CcSEcCtD
Temsirolimus—Asthenia—Capecitabine—colon cancer	0.000122	0.000825	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—colon cancer	0.000121	0.000816	CcSEcCtD
Temsirolimus—Pruritus—Capecitabine—colon cancer	0.00012	0.000814	CcSEcCtD
Temsirolimus—Diarrhoea—Capecitabine—colon cancer	0.000116	0.000787	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000115	0.00078	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—colon cancer	0.000115	0.000774	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—colon cancer	0.000113	0.000763	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—colon cancer	0.000113	0.000761	CcSEcCtD
Temsirolimus—Dizziness—Capecitabine—colon cancer	0.000113	0.00076	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—colon cancer	0.00011	0.000744	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—colon cancer	0.000109	0.000739	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—colon cancer	0.000109	0.000738	CcSEcCtD
Temsirolimus—Pain—Methotrexate—colon cancer	0.000108	0.000732	CcSEcCtD
Temsirolimus—Vomiting—Capecitabine—colon cancer	0.000108	0.000731	CcSEcCtD
Temsirolimus—Rash—Capecitabine—colon cancer	0.000107	0.000725	CcSEcCtD
Temsirolimus—Dermatitis—Capecitabine—colon cancer	0.000107	0.000724	CcSEcCtD
Temsirolimus—Headache—Capecitabine—colon cancer	0.000107	0.00072	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—colon cancer	0.000104	0.0007	CcSEcCtD
Temsirolimus—Nausea—Capecitabine—colon cancer	0.000101	0.000683	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—colon cancer	0.0001	0.000677	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—colon cancer	0.0001	0.000677	CcSEcCtD
Temsirolimus—Hypersensitivity—Methotrexate—colon cancer	9.34e-05	0.000631	CcSEcCtD
Temsirolimus—Asthenia—Methotrexate—colon cancer	9.09e-05	0.000614	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—colon cancer	8.97e-05	0.000606	CcSEcCtD
Temsirolimus—Diarrhoea—Methotrexate—colon cancer	8.67e-05	0.000586	CcSEcCtD
Temsirolimus—Dizziness—Methotrexate—colon cancer	8.38e-05	0.000566	CcSEcCtD
Temsirolimus—Vomiting—Methotrexate—colon cancer	8.06e-05	0.000544	CcSEcCtD
Temsirolimus—Rash—Methotrexate—colon cancer	7.99e-05	0.00054	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—colon cancer	7.98e-05	0.000539	CcSEcCtD
Temsirolimus—Headache—Methotrexate—colon cancer	7.94e-05	0.000536	CcSEcCtD
Temsirolimus—Nausea—Methotrexate—colon cancer	7.53e-05	0.000509	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—EGFR—colon cancer	6.38e-05	0.000705	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—PIK3CA—colon cancer	6.37e-05	0.000704	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—EGFR—colon cancer	6.35e-05	0.000702	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ODC1—colon cancer	6.32e-05	0.000699	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CHST5—colon cancer	6.32e-05	0.000699	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	6.31e-05	0.000698	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—HRAS—colon cancer	6.25e-05	0.000692	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—colon cancer	6.19e-05	0.000685	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—HRAS—colon cancer	6.15e-05	0.00068	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—KRAS—colon cancer	6.13e-05	0.000678	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—KRAS—colon cancer	6.13e-05	0.000678	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KRAS—colon cancer	6.13e-05	0.000678	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—PIK3CA—colon cancer	6.11e-05	0.000676	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—PIK3CA—colon cancer	6.08e-05	0.000672	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—KRAS—colon cancer	6.08e-05	0.000672	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—PIK3CA—colon cancer	6.05e-05	0.000669	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—KRAS—colon cancer	6.03e-05	0.000666	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—PIK3CA—colon cancer	6.02e-05	0.000666	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—EGFR—colon cancer	6.01e-05	0.000665	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—KRAS—colon cancer	6e-05	0.000663	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—colon cancer	5.99e-05	0.000663	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—PIK3CA—colon cancer	5.99e-05	0.000662	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—HRAS—colon cancer	5.98e-05	0.000662	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—colon cancer	5.92e-05	0.000655	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—colon cancer	5.9e-05	0.000653	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—HRAS—colon cancer	5.89e-05	0.000651	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1A—colon cancer	5.81e-05	0.000643	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CASP3—colon cancer	5.79e-05	0.000641	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	5.75e-05	0.000636	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—KRAS—colon cancer	5.68e-05	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—HRAS—colon cancer	5.65e-05	0.000625	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—PIK3CA—colon cancer	5.64e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—PIK3CA—colon cancer	5.64e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PIK3CA—colon cancer	5.64e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—HRAS—colon cancer	5.62e-05	0.000622	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—colon cancer	5.6e-05	0.000619	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—HRAS—colon cancer	5.6e-05	0.000619	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—PIK3CA—colon cancer	5.58e-05	0.000618	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—HRAS—colon cancer	5.57e-05	0.000616	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—HRAS—colon cancer	5.54e-05	0.000613	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—PIK3CA—colon cancer	5.54e-05	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—EP300—colon cancer	5.53e-05	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—AKT1—colon cancer	5.52e-05	0.000611	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—PIK3CA—colon cancer	5.51e-05	0.000609	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	5.46e-05	0.000604	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1A—colon cancer	5.45e-05	0.000603	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—colon cancer	5.44e-05	0.000601	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	5.43e-05	0.000601	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—AKT1—colon cancer	5.43e-05	0.0006	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—BCL2L1—colon cancer	5.34e-05	0.000591	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—AKT1—colon cancer	5.28e-05	0.000584	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—colon cancer	5.24e-05	0.000579	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—colon cancer	5.23e-05	0.000578	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—PIK3CA—colon cancer	5.22e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	5.21e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—HRAS—colon cancer	5.21e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HRAS—colon cancer	5.21e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—AKT1—colon cancer	5.2e-05	0.000575	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—HRAS—colon cancer	5.17e-05	0.000571	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—HRAS—colon cancer	5.12e-05	0.000566	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FGFR3—colon cancer	5.11e-05	0.000565	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—HRAS—colon cancer	5.1e-05	0.000564	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—SRC—colon cancer	5.05e-05	0.000558	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	4.99e-05	0.000552	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—AKT1—colon cancer	4.99e-05	0.000552	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—AKT1—colon cancer	4.97e-05	0.000549	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—AKT1—colon cancer	4.94e-05	0.000546	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—colon cancer	4.94e-05	0.000546	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—AKT1—colon cancer	4.92e-05	0.000544	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FGFR3—colon cancer	4.9e-05	0.000542	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—AKT1—colon cancer	4.89e-05	0.000541	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	4.89e-05	0.00054	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FGFR3—colon cancer	4.88e-05	0.00054	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NRAS—colon cancer	4.85e-05	0.000537	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA7—colon cancer	4.85e-05	0.000537	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—HRAS—colon cancer	4.82e-05	0.000534	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	4.82e-05	0.000533	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ODC1—colon cancer	4.77e-05	0.000528	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CHST5—colon cancer	4.77e-05	0.000528	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	4.62e-05	0.000511	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—AKT1—colon cancer	4.6e-05	0.000509	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—AKT1—colon cancer	4.6e-05	0.000509	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	4.6e-05	0.000509	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—AKT1—colon cancer	4.56e-05	0.000505	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—AKT1—colon cancer	4.52e-05	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—AKT1—colon cancer	4.5e-05	0.000498	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CHST5—colon cancer	4.5e-05	0.000497	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ODC1—colon cancer	4.5e-05	0.000497	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APC—colon cancer	4.48e-05	0.000496	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—EGFR—colon cancer	4.42e-05	0.000489	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.36e-05	0.000483	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—AKT1—colon cancer	4.26e-05	0.000471	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—BRAF—colon cancer	4.21e-05	0.000466	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—KRAS—colon cancer	4.18e-05	0.000462	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDH1—colon cancer	4.14e-05	0.000458	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	4.08e-05	0.000451	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—colon cancer	3.96e-05	0.000438	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PIK3CA—colon cancer	3.84e-05	0.000425	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.71e-05	0.00041	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—colon cancer	3.64e-05	0.000402	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—HRAS—colon cancer	3.55e-05	0.000393	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.44e-05	0.000381	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGFR3—colon cancer	3.42e-05	0.000378	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—colon cancer	3.4e-05	0.000376	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.35e-05	0.000371	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.32e-05	0.000367	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.24e-05	0.000359	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CTNNB1—colon cancer	3.18e-05	0.000352	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APC—colon cancer	3.14e-05	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—AKT1—colon cancer	3.14e-05	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1A—colon cancer	3.11e-05	0.000344	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BCL2L1—colon cancer	3.11e-05	0.000344	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.09e-05	0.000341	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CTNNB1—colon cancer	3.04e-05	0.000337	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3e-05	0.000332	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1A—colon cancer	2.99e-05	0.00033	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1A—colon cancer	2.97e-05	0.000329	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGFR3—colon cancer	2.97e-05	0.000329	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EP300—colon cancer	2.96e-05	0.000327	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BRAF—colon cancer	2.95e-05	0.000326	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ODC1—colon cancer	2.94e-05	0.000325	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CHST5—colon cancer	2.94e-05	0.000325	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.92e-05	0.000323	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—SRC—colon cancer	2.88e-05	0.000318	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EP300—colon cancer	2.83e-05	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NRAS—colon cancer	2.77e-05	0.000306	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SRC—colon cancer	2.76e-05	0.000306	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SRC—colon cancer	2.75e-05	0.000304	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGFR3—colon cancer	2.75e-05	0.000304	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.69e-05	0.000297	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.68e-05	0.000297	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NRAS—colon cancer	2.66e-05	0.000294	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NRAS—colon cancer	2.65e-05	0.000293	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.63e-05	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—colon cancer	2.52e-05	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APC—colon cancer	2.52e-05	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDH1—colon cancer	2.51e-05	0.000278	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.48e-05	0.000275	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—colon cancer	2.47e-05	0.000273	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—colon cancer	2.46e-05	0.000272	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—colon cancer	2.42e-05	0.000268	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—colon cancer	2.41e-05	0.000267	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KRAS—colon cancer	2.38e-05	0.000264	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BRAF—colon cancer	2.37e-05	0.000262	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCB1—colon cancer	2.31e-05	0.000256	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KRAS—colon cancer	2.29e-05	0.000253	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.28e-05	0.000252	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KRAS—colon cancer	2.28e-05	0.000252	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TYMS—colon cancer	2.27e-05	0.000251	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—colon cancer	2.21e-05	0.000245	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.21e-05	0.000244	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CA—colon cancer	2.19e-05	0.000242	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—colon cancer	2.15e-05	0.000238	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CTNNB1—colon cancer	2.13e-05	0.000236	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CA—colon cancer	2.1e-05	0.000233	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CA—colon cancer	2.09e-05	0.000232	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1A—colon cancer	2.08e-05	0.00023	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—colon cancer	2.03e-05	0.000224	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EP300—colon cancer	1.98e-05	0.000219	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—colon cancer	1.95e-05	0.000215	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—colon cancer	1.94e-05	0.000214	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SRC—colon cancer	1.93e-05	0.000213	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGFR3—colon cancer	1.92e-05	0.000213	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—colon cancer	1.91e-05	0.000212	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—colon cancer	1.88e-05	0.000208	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.86e-05	0.000206	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTNNB1—colon cancer	1.85e-05	0.000205	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NRAS—colon cancer	1.85e-05	0.000205	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1A—colon cancer	1.81e-05	0.0002	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—colon cancer	1.79e-05	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APC—colon cancer	1.77e-05	0.000195	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—colon cancer	1.73e-05	0.000191	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EP300—colon cancer	1.72e-05	0.000191	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—colon cancer	1.72e-05	0.000191	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—colon cancer	1.72e-05	0.00019	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CTNNB1—colon cancer	1.71e-05	0.000189	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—colon cancer	1.71e-05	0.000189	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—colon cancer	1.69e-05	0.000187	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SRC—colon cancer	1.68e-05	0.000185	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1A—colon cancer	1.67e-05	0.000185	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCB1—colon cancer	1.67e-05	0.000185	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BRAF—colon cancer	1.66e-05	0.000183	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TYMS—colon cancer	1.64e-05	0.000181	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NRAS—colon cancer	1.61e-05	0.000178	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—colon cancer	1.61e-05	0.000178	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KRAS—colon cancer	1.6e-05	0.000176	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EP300—colon cancer	1.59e-05	0.000176	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SRC—colon cancer	1.55e-05	0.000171	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NRAS—colon cancer	1.49e-05	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—colon cancer	1.47e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—colon cancer	1.47e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—colon cancer	1.42e-05	0.000157	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KRAS—colon cancer	1.39e-05	0.000154	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—colon cancer	1.39e-05	0.000153	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—colon cancer	1.38e-05	0.000153	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—colon cancer	1.36e-05	0.00015	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—colon cancer	1.36e-05	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KRAS—colon cancer	1.28e-05	0.000142	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—colon cancer	1.28e-05	0.000141	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—colon cancer	1.26e-05	0.00014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—colon cancer	1.24e-05	0.000138	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TYMS—colon cancer	1.24e-05	0.000137	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—colon cancer	1.21e-05	0.000134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CTNNB1—colon cancer	1.2e-05	0.000133	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—colon cancer	1.2e-05	0.000132	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCB1—colon cancer	1.19e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—colon cancer	1.18e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—colon cancer	1.18e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1A—colon cancer	1.17e-05	0.00013	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TYMS—colon cancer	1.17e-05	0.000129	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—colon cancer	1.16e-05	0.000129	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EP300—colon cancer	1.11e-05	0.000123	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—colon cancer	1.09e-05	0.00012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SRC—colon cancer	1.08e-05	0.00012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—colon cancer	1.06e-05	0.000117	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—EP300—colon cancer	1.05e-05	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NRAS—colon cancer	1.04e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—colon cancer	1.04e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—colon cancer	9.71e-06	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—colon cancer	9.69e-06	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—colon cancer	9.62e-06	0.000106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—colon cancer	9.5e-06	0.000105	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—colon cancer	9.14e-06	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KRAS—colon cancer	8.97e-06	9.92e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—colon cancer	8.77e-06	9.7e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—colon cancer	8.27e-06	9.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—colon cancer	8.25e-06	9.12e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—colon cancer	7.98e-06	8.82e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—colon cancer	7.78e-06	8.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCB1—colon cancer	7.77e-06	8.59e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TYMS—colon cancer	7.63e-06	8.44e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—colon cancer	7.63e-06	8.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—EP300—colon cancer	7.6e-06	8.41e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—colon cancer	6.9e-06	7.63e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—colon cancer	6.74e-06	7.45e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—colon cancer	6.5e-06	7.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—colon cancer	6.36e-06	7.03e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—EP300—colon cancer	5.74e-06	6.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—colon cancer	5.63e-06	6.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—EP300—colon cancer	5.41e-06	5.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—colon cancer	5.4e-06	5.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—colon cancer	4.6e-06	5.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—colon cancer	4.25e-06	4.7e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—colon cancer	4.25e-06	4.69e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—colon cancer	4e-06	4.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EP300—colon cancer	3.54e-06	3.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—colon cancer	3.47e-06	3.84e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—colon cancer	3.27e-06	3.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—colon cancer	2.62e-06	2.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—colon cancer	2.14e-06	2.36e-05	CbGpPWpGaD
